The recent hantavirus alarm aboard the cruise ship MV Hondius is a reminder that dangerous infections do not always begin in crowded cities or hospitals. In early May 2026, scientific reports described three confirmed hantavirus infections linked to the ship, including one passenger who died, and five additional suspected cases, including two more deaths. The ship had sailed from Argentina, where Andes virus – a hantavirus known for rare person-to-person spread – has been under scrutiny.For Nepal, the lesson is not panic. It is preparedness.Hantavirus is not new, and it is not one virus. It is a family of rodent-borne viruses found in different parts of the world. Rats, mice and other wild rodents can carry these viruses without appearing sick. Humans are accidental hosts. Infection usually occurs when people inhale dust contaminated with urine, droppings, or saliva from infected rodents. It can also occur when contaminated material enters the eyes, nose, mouth or broken skin. Rodent bites are possible but uncommon.This biology matters. Hantavirus is an enveloped, negative-sense RNA virus with three genome segments: small, medium, and large. These encode the nucleocapsid protein, viral surface glycoproteins, and RNA-dependent RNA polymerase. After entering human cells, the virus uses its own polymerase to copy its genetic material and produce new viral particles. The most dangerous damage, however, is not simply from the virus "eating" cells. Severe disease is driven by dysfunction of the endothelial lining of small blood vessels. The vessels become leaky. Fluid moves into tissues. In one form, the lungs fill with fluid. In another, the kidneys and circulation are badly affected.There are two main clinical patterns. In the Americas, hantaviruses can cause hantavirus pulmonary syndrome, also called hantavirus cardiopulmonary syndrome. This can progress from fever and body aches to sudden respiratory failure and shock. In Europe and Asia, hantaviruses more often cause hemorrhagic fever with renal syndrome, marked by fever, low blood pressure, bleeding tendency, and kidney injury. Seoul virus, associated with rats, is found globally and can cause kidney-related diseases.The early symptoms are ordinary enough to be missed: fever, fatigue, muscle pain, headache, chills, nausea, vomiting, diarrhoea, or abdominal pain. In pulmonary disease, cough, and shortness of breath may appear several days later. By then, deterioration can be rapid. The U.S. Centers for Disease Control and Prevention notes that hantavirus pulmonary syndrome may be fatal in about 38 per cent of people who develop respiratory symptoms.The kidney form also varies in severity. Hemorrhagic fever with renal syndrome usually begins one to two weeks after exposure, though rarely it can take up to eight weeks. Hantaan and Dobrava virus infections can have case-fatality rates of about 5-15 per cent, while Seoul, Saaremaa, and Puumala infections are usually milder, with fatality below 1 per cent. Even when patients survive, recovery can take weeks or months.The MV Hondius incident attracted attention because Andes virus is unusual. Most hantaviruses do not spread from one person to another. Andes virus is the main exception. Still, its person-to-person transmission is rare and typically linked to close, prolonged contact.That is why hantavirus is unlikely to become the next COVID-like pandemic. Most infections require exposure to infected rodents or their waste. But this should not lull us into indifference.For Nepal, the immediate risk from the cruise-ship outbreak is low unless a person has a direct link. But Nepal should take the wider signal seriously. South Asia has the ecological and social conditions in which rodent-borne infections can be missed.Nepal's vulnerability is not theoretical. Many people work in agriculture, store grain at home, sleep in temporary shelters, clean old houses, live near fields or forests, and encounter rodents in markets, warehouses, restaurants, schools and transport hubs. Floods, landslides, earthquakes and displacement can bring humans and rodents into closer contact. Climate variability can change rodent populations and movement. In such settings, hantavirus-like illness could easily be labelled dengue, influenza, COVID-19, leptospirosis, scrub typhus, bacterial sepsis, or kidney infection.The prevention message is practical and unglamorous: control rodents and clean safely. Food and grain should be stored in rodent-proof containers. Garbage should be covered and removed. People should avoid sleeping in rodent-infested rooms and should not handle dead rodents with bare hands. Dry sweeping of rodent droppings is risky because it can push contaminated dust into the air. Suspected rodent urine, droppings, or nesting material should be wetted with disinfectant or bleach solution, left for several minutes, and then wiped up with gloves. Heavily infested areas should be ventilated before cleaning.For clinicians, the key is exposure history. A patient with fever, severe body aches, abdominal symptoms, breathing difficulty, low platelets, kidney injury, shock or unexplained lung edema should be asked: Have you cleaned a rodent-infested room? Worked in grain storage? Slept in a shed? Camped or worked in forests or fields? Handled rodents? Recently travelled to an affected area? One question can change the diagnosis.For Nepal's public-health system, hantavirus should be a preparedness issue, not a panic issue. The country needs better syndromic surveillance for severe febrile illness, laboratory referral pathways for unusual viral infections, rodent ecology studies, clinician training, and public messaging before outbreaks occur.The hantavirus scare at sea should push Nepal towards a more mature public-health conversation. We should stop measuring every infection only by whether it can become a pandemic. Some threats are local, rare, and still deadly. Hantavirus is one of them. Nepal's best defense is not alarm. It is clean housing, rodent control, safe food storage, careful cleaning, better diagnostics and doctors who remember to ask about rodents.Dr GC is the co-founder of the Kathmandu Research Institute for Biological Sciences, Nepal and a postdoctoral scientist at Cedars-Sinai, USA
